Mouse Adam12 ELISA Kit (V2LY-0626-LY2313)

Mohamad, A., Hassan, R., Azlan Husin, M. F. J., & Sulong, S. (2021). Aberrant Methylation of Tumour Suppressor Gene ADAM12 in Chronic Lympocytic Leukemia Patients: Application of Methylation Specific-PCR Technique. Asian Pacific Journal of Cancer Prevention: APJCP, 22(1), 85.

Wang, L., Tan, Z., Zhang, Y., Kady Keita, N., Liu, H., & Zhang, Y. (2020). ADAM12 silencing promotes cellular apoptosis by activating autophagy in choriocarcinoma cells. International journal of oncology, 56(5), 1162-1174.

Bernstein, H. G., Keilhoff, G., Dobrowolny, H., Lendeckel, U., & Steiner, J. (2020). From putative brain tumor marker to high cognitive abilities: Emerging roles of a disintegrin and metalloprotease (ADAM) 12 in the brain. Journal of Chemical Neuroanatomy, 101846.

Aguilar Muniz, L. S., Gonzalez Galarza, F. F., Arguello Astorga, R., Prieto Hinojosa, A. I., Hernandez Teran, F., Mendez Hernandez, A., ... & Arellano Pérez Vertti, R. D. (2020). Analyses of the Genetic Polymorphisms rs3740199 and rs1871054 of the ADAM12 Gene and the Alleles at the rs2073508 Loci of the TGFB1 Gene and Their Contribution to Susceptibility to Primary Knee Osteoarthritis. Genetic testing and molecular biomarkers, 24(6), 375-380.

Albrechtsen, R., Wewer Albrechtsen, N. J., Gnosa, S., Schwarz, J., Dyrskjøt, L., & Kveiborg, M. (2019). Identification of ADAM12 as a novel basigin sheddase. International journal of molecular sciences, 20(8), 1957.

Xiong, L., Yan, W., Zubia, E., Zhou, Y., Zhang, Y., Duan, Q., ... & Xu, G. (2018). Quantitative proteomics and biochemical analyses reveal the role of endoplasmin in the regulation of the expression and secretion of A Disintegrin And Metalloproteinase 12. Journal of proteomics, 182, 34-44.

Hu, X., Sun, G., & Wang, W. (2017). Association of ADAM 12 polymorphisms with the risk of knee osteoarthritis: meta-analysis of 5048 cases and 6848 controls. Rheumatology international, 37(10), 1659-1666.

Wu, Z., Xu, X. W., & Zhang, X. W. (2017). The association of ADAM12 polymorphism with osteoarthritis susceptibility: a meta-analysis. Therapeutics and clinical risk management, 13, 821.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols